BIL vs SHV: returns, risk and drawdowns compared
SPDR Bloomberg 1-3 Month T-Bill ETF against iShares Short Treasury Bond ETF, over the same 19 years (June 2007 to October 2026) with dividends reinvested.
Data updated October 2026
BIL
SPDR Bloomberg 1-3 Month T-Bill ETF
10,000 became
13,733
- A year on average
- +1.6%
- Annual volatility
- 0.7%
- Deepest fall
- −0.4%
- Worst month
- −0.1%
SHV
iShares Short Treasury Bond ETF
10,000 became
13,466
- A year on average
- +1.5%
- Annual volatility
- 0.6%
- Deepest fall
- −0.3%
- Worst month
- −0.1%
BIL came out ahead by 0.1 percentage points a year from June 2007 to October 2026. BIL swung more (0.7% against 0.6% a year). The correlation of monthly returns was 0.86: they usually moved together.
Growth of 10,000: BIL vs SHV
Who was ahead, and when
The gap between the two over the previous three years, at each month-end. Above zero BIL had returned more, below zero SHV. BIL was ahead in 40% of the 198 three-year periods.
Annualised 3-year return of BIL minus that of SHV, in percentage points a year.
Falls from the previous high
Month-end values. Deepest fall: BIL −0.4%, SHV −0.3%.
All the figures
| BIL | SHV | |
|---|---|---|
| Annual return (CAGR) | +1.6% | +1.5% |
| Total return | +37% | +35% |
| Annual volatility | 0.7% | 0.6% |
| Deepest fall (month-end) | −0.4% | −0.3% |
| Worst month | −0.1% | −0.1% |
| Best month | +0.9% | +0.9% |
| Positive months | 62% | 71% |
| Best year | 2024: +5.2% | 2024: +5.1% |
| Worst year | 2015: −0.1% | 2021: −0.1% |
| 1-year return | +3.7% | +3.6% |
| 5 years, a year | +3.7% | +3.6% |
| 10 years, a year | +2.4% | +2.4% |
| Trading currency | USD | USD |
First nine rows: the same 233 months for both funds. Trailing returns: to each fund’s last close.
Year by year
Full calendar years both funds were trading. The higher of the two each year is in bold.
Holding both: half BIL, half SHV
| BIL alone | SHV alone | 50/50 | |
|---|---|---|---|
| A year on average | +1.6% | +1.5% | +1.6% |
| Annual volatility | 0.7% | 0.6% | 0.6% |
| Deepest fall (month-end) | −0.4% | −0.3% | −0.2% |
| Worst month | −0.1% | −0.1% | −0.1% |
Because the two did not always move together, the mix swung less than the average of the two (0.6% against 0.6%). Rebalanced to 50/50 every month, before costs.
Questions
Which has returned more, BIL or SHV?
From June 2007 to October 2026, BIL returned +1.6% a year and SHV +1.5% a year, with dividends reinvested. Over rolling 3-year periods BIL did better in 40% of cases. Past returns do not predict future returns.
Which is riskier, BIL or SHV?
Over the same months annual volatility was 0.7% for BIL and 0.6% for SHV; the deepest fall from a month-end high was 0.4% and 0.3%, and the worst single month −0.1% and −0.1%.
How correlated are BIL and SHV?
The correlation of their monthly returns was 0.86: they usually moved together. Combining them has historically given some diversification.
What about holding both BIL and SHV?
Half in each, rebalanced every month, returned +1.6% a year over the same period, with 0.6% annual volatility and a deepest month-end fall of 0.2%.
More comparisons
- BIL — SPDR Bloomberg 1-3 Month T-Bill ETFReturns, drawdowns and risk
- SHV — iShares Short Treasury Bond ETFReturns, drawdowns and risk
- SGOV vs BIL
- BIL vs XEON
- SGOV vs SHV
- SHV vs XEON
- Portfolio backtesting, explainedRebalancing, costs and attribution
- Alternatives to Portfolio Visualizer, comparedWhich tool fits which job
How the figures are calculated
Total return in the fund’s trading currency, from end-of-day prices with dividends reinvested on the ex-date. The fund’s own ongoing charges are already reflected in its price; trading costs, taxes and currency conversion are not included. Past returns do not predict future returns.
The comparison uses only the months in which both funds have prices, so the figures cover the same period even when one fund is older.
Source: MarketStack end-of-day prices, total return with dividends reinvested. Figures are historical and descriptive; they are not forecasts and not investment advice. MEDGE Capital does not recommend buying or selling any instrument. Risk disclaimer.